about
Gene delivery technologies for cardiac applicationsIntracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction?Elucidation of a novel pathway through which HDAC1 controls cardiomyocyte differentiation through expression of SOX-17 and BMP2Myocardial gene transfer: routes and devices for regulation of transgene expression by modulation of cellular permeabilityIn vivo selective expression of thyroid hormone receptor α1 in endothelial cells attenuates myocardial injury in experimental myocardial infarction in mice.Early vessel destabilization mediated by Angiopoietin-2 and subsequent vessel maturation via Angiopoietin-1 induce functional neovasculature after ischemia.Synthetic chemically modified mRNA (modRNA): toward a new technology platform for cardiovascular biology and medicine.Implication of the miR-184 and miR-204 competitive RNA network in control of mouse secondary cataract.MicroRNA therapeutics in cardiovascular medicine.Negative pressure wound therapy promotes vessel destabilization and maturation at various stages of wound healing and thus influences wound prognosis.Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.Liposome technology for cardiovascular disease treatment and diagnosis.Ischemia-induced copper loss and suppression of angiogenesis in the pathogenesis of myocardial infarction.Vascular endothelial growth factor-delivery systems for cardiac repair: an overview.Concise review: cell therapy and tissue engineering for cardiovascular disease.Regenerative therapies using cell sheet-based tissue engineering for cardiac disease.Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease.Coupling Aptamers to Short Interfering RNAs as Therapeutics.The association of depressed angiogenic factors with reduced capillary density in the Rhesus monkey model of myocardial ischemia.Gene Therapy in Heart Failure.Selective Pressure-Regulated Retroinfusion for Gene Therapy Application in Ischemic Heart Disease.Tumor necrosis factor alpha protects heart cultures against hypoxic damage via activation of PKA and phospholamban to prevent calcium overload.Ultrasound microbubbles mediated miR-let-7b delivery into CD133 ovarian cancer stem cells
P2860
Q26863362-BB68DF2B-4E38-4945-A0BB-85A73152ABB9Q27025843-93A6440C-CD2A-4EC5-8E26-6740E65F3E45Q27318649-EFF5B292-F20A-478A-A9E9-B030BC043A41Q30440788-6ABB04A7-CD59-4B1F-9FFF-C9C5824CD532Q34001618-10BCF792-E8C1-426D-9D8D-BC950581A153Q34685212-77C31E9C-3062-40C9-8874-BD99B2E1B10FQ35319305-E194144D-1DEC-490A-8E2D-E80F6817BE83Q35973315-22B6C989-6856-4DC1-A42B-88739667F0E9Q36037919-895B247F-3BC0-4D41-ADE1-CDAED43606D8Q36742246-5A29474A-CACB-4CC7-BFF3-CC1EF284C709Q36915712-1A3C4B09-A53A-49A5-8939-918B4948A55EQ37974931-C993582E-36AB-4A46-A4F8-57E98E003231Q38014352-80B6EE9E-CCA4-4674-9ED8-3F921D46F7C8Q38022017-5CD98002-A957-45F4-9CB2-AA437707B440Q38063849-C30DE41C-5811-4F12-B5AE-181C80AF6121Q38658511-5DAACD0E-5757-4A1A-B262-13D5671233FCQ38773475-6F2EDF2C-B696-42BE-9F09-B5BE6E55DD82Q38976705-67478FE8-4378-4DB9-BBC9-EA506FB10247Q40017141-93EDA729-0E17-45F6-8705-51B7141FBC20Q45861410-D66D4168-30A9-4FD9-9655-A602E106444BQ45862456-C729EEE9-E4E7-405F-BE8C-61A10F6FEFE0Q51688058-E478A7FB-9F2A-4A70-97A1-EF9BE211C776Q59125981-1972E9B4-9B48-4334-AAF4-C215AC966260
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gene therapy for ischemic heart disease.
@en
Gene therapy for ischemic heart disease.
@nl
type
label
Gene therapy for ischemic heart disease.
@en
Gene therapy for ischemic heart disease.
@nl
prefLabel
Gene therapy for ischemic heart disease.
@en
Gene therapy for ischemic heart disease.
@nl
P2860
P1476
Gene therapy for ischemic heart disease
@en
P2093
Christian Kupatt
Teresa Trenkwalder
P2860
P304
P356
10.1517/14712598.2011.570749
P407
P50
P577
2011-03-25T00:00:00Z